Bank North has now raised c.£30m of capital and secured its banking licence (24 August 2021). What was an uncertain “jam tomorrow” story will soon be generating income. Bank North
Cizzle Biotechnology Holdings plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for early detection of different forms of
In this note, we demonstrate how the strength of Pantheon International plc (LON:PIN) primary platform and the active management of its portfolio add value in the attractive secondary (30% of
Palace Capital plc (LON:PCA) 15 November interim results have led us to upgrade our profit and dividend forecasts modestly. Commercial property income is robust, and Hudson Quarter (HQ) residential profit
International Biotechnology Trust plc (LON:IBT) was established in 1994 to provide institutional and retail investors with the opportunity to participate in global biotechnology and life science companies, from venture-stage (via
This note analyses the unique advantages that Intermediate Capital Group (ICG plc) has brought to ICG Enterprise Trust plc (LON:ICGT) since becoming the manager in 2016 and contributing to the
Life assurance consolidators should be boring most of the time, perhaps apart from when they do some M&A. Operationally, Chesnara Plc (LON:CSN) has been close to achieving that, although recent
Cornerstone FS plc (LON:CSFS) is a provider of foreign exchange (forex), payment and currency risk management services, with a focus on small and medium-sized enterprises (SMEs) internationally. As one of
In this note, we explore three aspects of Volta Finance plc (LON:VTA) portfolio, highlighting their simplification – simplified. Firstly, unless there is a compelling, opportunistic case, new investments will be
We reviewed Appreciate Group plc (LON:APP) business model in our initiation, Solid core + digital disruption = unique model, published on 1 September. On 23 November, APP released its interim
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
